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Wharton’s jelly (WJ) is the gelatinous connective tissue from the umbilical cord. It 
is composed of mesenchymal stem cells, collagen fibers, and proteoglycans. The 
stem cells in WJ have properties that are interesting for research. For example, 
they are simple to harvest by noninvasive methods, provide large numbers of 
cells without risk to the donor, the stem cell population may be expanded in 
vitro, cryogenically stored, thawed, genetically manipulated, and differentiated 
in vitro. In our study, we investigated the effect of human cerebrospinal fluid 
(CSF) on neural differentiation of human WJ stem cells. 
Material & Methods
The cells in passage 2 were induced into neural differentiation with different 
concentrations of human cerebrospinal fluid. Differentiation along with neural 
lineage was documented by expression of three neural markers: Nestin, 
Microtubule-Associated Protein 2 (MAP2), and Glial Fibrillary Astrocytic 
Protein (GFAP) for 21 days. The expression of the identified genes was 
confirmed by Reverse Transcriptase PCR (RT-PCR). 
Results
Treatment with 100 and 200μg/ml CSF resulted in the expression of GFAP and 
glial cells marker on days 14 and 21. The expression of neural-specific genes 
following CSF treatment was dose-dependent and time-dependent. Treatment 
of the cells with a twofold concentration of CSF, led to the expression of MAP2 
on day 14 of induction. No expression of GFAP was detected before day 14 or 
MAP2 before day 21, which shows the importance of the treatment period. In 
the present study, expression analysis for the known neural markers: Nestin, 
GFAP, and MAP2 using RT-PCR were performed. The data demonstrated that 
CSF could play a role as a strong inducer.
Conclusion
 RT-PCR showed that cerebrospinal fluid promotes the expression of Nestin, 
MAP2, and GFAP mRNA in a dose-dependent manner, especially at a 
concentration of 200 μl/ml. In summary, CSF induces neurogenesis of WJ 
stem cells that encourages tissue engineering applications with these cells for 
treatments of neurodegenerative defects and traumatic brain injury. 
Keywords: Cerebrospinal fluid; Neurogenesis; Mesenchymal stem cells; 
Nestin; Microtubule-associated protein 2; Glial fibrillary astrocytic protein
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teratomas(7).
They are believed to be more primitive than MSCs 
derived from other tissue sources (8).Cerebrospinal fluid 
(CSF) circulates within the ventricles of the brain, and 
surrounds the brain and spinal column. The total volume 
of CSF in the human ventricular system is ca. 125 ml. 
CSF contains small molecules, salts, peptides, proteins, 
and enzymes, among others (9). The protein component 
of CSF consists of brain-derived proteins as well as 
many proteins that are also abundant in plasma (10). 
Recent studies suggest that CSF plays an important role 
in physiological as well as path physiological processes 
of the brain including adult neurogenesis (11, 12 and 13).
Recent investigations concentrated mainly on proteins, 
membranous particles, amino acids, and on growth factors 
such as FGF2 as the components of CSF influencing 
neuroectodermal cell behavior (14, 15, 16, 17 and 18). 
In human CSF, many proteins with a known influence 
on cell survival, neural and glial differentiation, and 
proliferation and signal transduction were found (such 
as transthyretin, serine, retinol binding protein, heparin 
sulfate, several apo-lipoproteins, and FGF2) (19).
In 2003, Mitchell et al described neural differentiation 
of human  WJ using two main and well-known neural 
differentiation inducers: DMSO and BHA(20).We 
present our findings as to the effect of CSF, a human 
body fluid containing different growth factors, on neural 
differentiation of human WJ MSCs evaluating three 
neural marker expression: MAP2, Nestin, and GFAP. 
Materials & Methods
Wharton’s jelly stem cell culture
Human WJ stem cells (passage 2; normal cerotype) 
were obtained from Shahid Beheshti University of 
Medical Sciences. Human WJ stem cells were Isolated 
from fresh human umbilical cords. Cells were kept in 
an undifferentiated state in Dulbecco’s Modified Eagle 
Medium (DMEM) (Invitrogen) supplemented with 10% 
fetal bovine serum (FBS; Gibco) and 1% pen-strepto 
(Gibco) and medium exchange was done every 2 days 
(Fig1). Reaching 80% confluence, the adherent cells 
were detached with 0.05% trypsin-EDTA, counted with 
Trypan Blue exclusion, and reseeded at 3000 cells/cm2 
to reach the 90% of confluence after 3-4 population 
doublings.
Introduction 
Neural stem cells are immature, uncommitted cells 
in developing brains and an adult nervous system 
that can differentiate into neurons, astrocytes, and 
oligodendrocytes. However, neural stem cells from the 
central nervous system are rare, require an invasive 
procedure to obtain, and may have a more limited 
potential to proliferate in culture than embryonic or 
other adult stem cells. 
Mesenchymal stem cells or multipotent stromal cells 
(MSCs) are adult multipotent cells that have been 
isolated from almost all type of connective tissue .They 
have two main stem cells properties: self-renewal and 
ability of differentiation into mesodermal, endodermal, 
and even ectodermal lineages under appropriate in vitro 
conditions (2).
MSCs appear to have a remarkable clinical potential in 
tissue regeneration and immune regulatory therapeutic 
applications. This source of stem cells was first 
identified by Friedenstein et al as fibroblast-like cells 
with clonogenic potential due to evoking only minimal 
immunoreactivity (3) and secretory of bio-active factors 
within- inflammatory and immuno-modulatory effects 
in vivo (4). To date, the best characterized source of 
MSCs is bone marrow (BM) and most of the knowledge 
regarding MSCs is based on BM studies. However, 
processing and harvesting of MSCs from BM has certain 
limitations as follows: a highly invasive procedure to the 
donors, significant reduction in number of MSCs per 
nucleated marrow cell with age, decline of differentiation 
potential, and proliferation efficiency of BM-MSCs with 
increasing age (5).
Postnatal stem cells, such as mesenchymal stem cells as 
regards to their easy isolation and high proliferation as 
well as differentiation potential may offer a better source 
of cells for therapeutic purposes and neural repair.
Brand new sources of MSCs and an alternative source 
is the umbilical cord that, as a fetus-derived tissue, can 
be easily obtained and processed and is noncontroversial 
(6). Wharton’s jelly (WJ) from umbilical cord possesses 
desirable characteristics such as a large, rapidly available 
donor pool, noninvasive and painless collection 
procedure, and ethically noncontroversial source of 
MSCs. WJ-MSCs have extensive in vitro expansion 
capabilities, wide multipotency, and do not induce 
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expression of neural markers, microtubule-associated 
protein 2 [Map2] as a mature neuron marker), Nestin 
(as an immature neuron marker) and (Glial fibrillary 
acidic protein [GFAP] as mature astrocyte marker), was 
assessed by Reverse Transcriptase-PCR (RT-PCR).
Total RNA was extracted using an Easy Blue Total 
RNA Extraction Kit according to the manufacturer’s 
instructions. Samples were treated with RNase-free 
DNase I (Takara) to avoid DNA contamination. Extracted 
RNA concentration was measured by a NanoDrop™ 
2000 (Spectrophotometers; Thermo Scientific, USA) 
and cDNA was synthesized from 1µg of RNA using 
cDNA Reverse Transcription Kit (Takara) according to 
the manufacturer’s instructions.
The samples were incubated at 42°C for 60 min, followed 
by 10 min incubation at 72°C. Polymerase chain reaction 
(PCR) was carried out using standard protocols with 
Taq DNA Polymerase (Gibco-BRL). PCR conditions 
included a first step of 3 minutes at 94°C, a second step 
of 25–30 cycles of 30 seconds at 94°C, a 45-second 
annealing step at 53–62°C, 1 minute at 72°C, and a final 
step of 10 minutes at 72°C. The expression value of each 
gene was normalized to the amount of ß-Actin cDNA 
to calculate a relative amount of RNA present in each 
sample. The PCRs were performed in triplicate. Table 1 
provides details of the primers and amplicon size. The 
final products were examined by gel electrophoresis on 
1.5%agarose ethidium bromide-stained gels.
Imaging and Statistical analysis
Images were obtained with the Olympus 
Stereomicroscope and invert microscope. The data 
were stated as mean ± SD (standard deviation) on 
version 16 of SPSS statistical software. Statistical 
significance between groups was calculated by 
independent Student t test assuming equal variance. 
P <0.05 was considered statistically significant.
Results
Our initial interest was to determine whether new factors 
into the cell environment will affect the faith of the cells. 
Trypan blue cell staining showed that there was no 
significant cell death after treating cells with CSF (near 
10%) when compared to routine neural differentiation 
factor retinoic acid (18%). In addition, our results 
Normal child CSF was provided after informed consent 
from Mofid Children’s Hospital. Collected CSF was 
transferred to a sterile microtube on ice and centrifuged 
(Hettich lab technology universal, 320R, Germany) at 
8000 rpm for 10 min to remove cells or debris, and then 
supernatants were passed through 0.45-μm and 0.22-μm 
filters sequentially and were stored at −20°C until use.
Differentiation of Human Wharton’s jelly stem cells
Cells were seeded into T25 cell culture flasks in the 
presence of DMEM-F12 medium supplemented with 
1% FBS and 1% penicillin-streptomycin. Neural 
differentiation of cells was induced by culturing the 
cells in the medium containing the collected CSF as 
following. Before treatment, the cells were divided into 
7 groups and each group contained cells treated with 
human CSF at different periods of time as follows: in 
group A the cells were treated with CSF for 1day; in 
group B for 4days; in group C for 7days; in group D 
for 14days and in group E the cells were treated with 
CSF for 21days; in group F the cells were treated 
with all trans Retinoic acid (10µl/ml); and in group 
G the cells were cultured in only DMEM-F12 media 
supplemented with 1% FBS. Additionally, group(s) F 
and G was considered as positive and negative controls, 
respectively. Each group was subdivided into two 
subgroups and two concentrations (100µl and 200 µl 
per ml) of CSF were added to each subgroup. The whole 
process was performed in triplicate.
Cell viability
The addition of any new factors into the cell environment 
will affect the faith of the cells. The cytotoxicity of added 
factors depends on the additional dose. Different studies 
have shown that even a high dose of an inducer might 
have a cytotoxic effect on the cells. We stained with 
Trypan Blue after each harvest (before RNA extraction) 
and the percentage of viable cells was evaluated using 
hemocytometer lam to investigate cell viability and the 
effect of human CSF as an exogenous protein cocktail 
and the dosages on cell viability.
RNA extraction and cDNA synthesis
RNA extraction was performed at days 1, 4,7,14, and 
21 of differentiation after initial cell seeding. The 
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demonstrate that no significant differences in cell death 
were observed between the two concentrations of inducer. 
Data are expressed as mean ±SD. For comparison of 
quantitative measures, the values were subjected to 
statistical analysis by using the Student’s t-test and were 
considered significant with p <0.05 (Fig2).
The influence of CSF on characteristics of isolated WJ 
stem cells was investigated with RT- PCR. In order to 
evaluate effect of CSF on neural gene expression in WJ-
derived MScs, neural gene expression was assessed and 
compared in all groups. Three established transcripts, 
Nestin, MAP-2, and GFAP were evaluated in cells after 
cultivation. Previous studies had shown that human 
WJ stem cells are Nestin positive cells but in our study, 
treatment with CSF exhibited a remarkable increase 
in expression of Nestin during 21 days of treatment. 
Treatment with 100 and 200 μg/ml CSF resulted in the 
expression of GFAP, the glial cells marker, on days 14 and 
21, respectively; when compared with the cells cultured 
in the control groups. MAP2, the marker of neural 
differentiation, showed a delayed expression on day 21 
of treatment with100 μg/ml CSF. GFAP is expressed 
before MAP2 at 100ug/ml concentration. On Day 14, 
at 200ug/ml CSF concentration, GFAP expression is 
higher than MAP2 expression (Fig3). The expression 
of neural-specific genes that occurred following CSF 
treatment was found to be dose-dependent and time-
dependent. Treatment of the cells with a twofold 
concentration of CSF led to expression of MAP2 on day 
14 of induction to demonstrate the effect of inducer dose 
on the differentiation of stem cells. Figure 2 shows that 
no expression of GFAP was detected before day 14 or 
MAP2 before day 21 to show the importance of treatment 
period. In the present study, expression analysis for the 
known neural markers Nestin, GFAP, and MAP2 using 
RT-PCR was performed and the data demonstrated that 
CSF could play a role as a strong inducer.
Discussion
The potential for self-renewal and multi lineage 
differentiation indicate that MSCs are an attractive 
therapeutic tool. Several reports have indicated that extra 
embryonic tissues might be considered a potential source 
for populations of cells that phenotypically resemble 
BM-MSC (21). This has been demonstrated for the 
placenta (22), amniotic fluid (23), amniotic membrane 
(24), umbilical cord blood (25), and umbilical cord 
matrix (26).
MSCs isolated from WJ and bone marrow are shown 
to have an inherent potential to differentiate along the 
mesodermal lineage such as adipogenic, chondrogenic 
and osteogenic cells (27). Many reports have shown 
that WJ is an alternative source for human MSCs for 
experimental and clinical applications in comparison 
with BM (28).
A number of neurodegenerative diseases result in cell 
death. Cell-based therapies involving stem cells aim to 
replace these lost cells or repair damaged areas, thus 
providing functional recovery. However, before the 
potential of stem cell-based therapies can be realized, it 
is important to understand the behaviour of these cells 
after implantation in vivo (29). Stem cells derived from 
WJ have a utility in autologous stem cell therapy; they 
not only reduce the need for immunosuppression but are 
harvested relatively easily in the clinic. In the present 
study, we investigate the potential of human CSF on 
neural differentiation of human WJ stem cells. We report 
a novel method to modulate the differentiation of human 
WJ stem cells into neurons involving the use of Normal 
child CSF. WJ-MSCs from the umbilical cord are of 
epiblast origin and show multipotent characteristics 
between embryonic stem cells and adult stem cells. They 
have higher proliferation rates and a lower tendency to 
differentiate into adipocytes when compared to bone 
marrow MSCs (30). Moreover, WJ-MSCs can replicate 
through many passages without karyotypic changes or 
senescence; and they can retain stemness properties for 
a long time in-vitro. 
Weiss et al (31) demonstrated the differentiation capacity 
of human umbilical cord mesenchymal stem cells into 
dopaminergic neurons. Most recently, Carlin et al (32) 
demonstrated some embryonic stem cell markers, such 
as Oct-4, Sox-2, and Nanog for the first time in porcine 
umbilical cord matrix cells. Through many passages 
without karyotypic changes, they are similar to bone 
marrow stromal and other MSCs in their surface marker 
CD 13, CD 29, CD 44, CD 73, CD 90, and CD 105; and 
negative for CD 34, CD 45, CD 14, CD 33, and HLA- 
DR (33). 
We have demonstrated that human CSF, a normal body 
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Fig 1. Morphology of passage 3 WJ-MSCs cultured in 
DMEM  medium containing 10% FBS (x40)
Fig 2. Cell viability diagram
Fig 3.  RT-PCR results, A: day 1, B: day 4, C: day 7, D: day 14, E: day 21, F: RA 




























































































































































Table 1. Primers Sequence
Product 
size (bp)
Tann (ºC)Antisense primerSense primerGene
17258 ºC5’-CCCACTTTCTTCCTCATCTG -3’5’-CTCTGACCTGTCAGAAGAAT-3’Nestin
18053 ºC5’- CCTGCTTGCCGGGCTCACCCGA-3’5’-CCAATGGATTCCCATACAGG-3’Map2
16553 ºC5’- CCTCCGTGTAGTGACCCTTG-3’5’- AACGAGGCCTCTTCTCACAA-3’GFAP
35762 ºC5’- AGTCCGCCTAGAAGCATTTG-3’5’- CACTCTTCCAGCCTTCCTTC-3’ß-actin
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fluid, has a noteworthy potential to induce differentiation 
in vitro culture. In this study expression of Nestin, GFAP, 
and MAP2 markers was significantly increased compare 
to with the cells cultured in the control groups (p<0.001). 
The system used in this study has the advantage that 
human CSF contains several growth factors such as 
bFGF or EGF along with other factors that promote 
and enhance the development of neural cells apart from 
glial induction and natural neural inducers. In this study, 
even high concentration of human CSF, has shown a 
low cytotoxic effect on cells compared with other well-
known inducers. In summary, differentiation can be 
induced by human CSF in a dose dependent manner. 
Thus it seems the WJ MSC-derived neurons can be used 
for treating neurodegenerative disease and can be easily 
obtained from discarded cord blood.
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